SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $677,018 | +2.1% | 675,000 | 0.0% | 0.64% | -13.2% |
| Q4 2022 | $663,188 | +0.9% | 675,000 | 0.0% | 0.74% | -14.0% |
| Q3 2022 | $657,000 | +0.2% | 675,000 | 0.0% | 0.86% | -2.7% |
| Q2 2022 | $656,000 | -1.2% | 675,000 | 0.0% | 0.88% | +14.8% |
| Q1 2022 | $664,000 | -0.2% | 675,000 | +99900.0% | 0.77% | +8.0% |
| Q4 2021 | $665,000 | -1.0% | 675 | 0.0% | 0.71% | -32.9% |
| Q3 2021 | $672,000 | +0.9% | 675 | 0.0% | 1.06% | +27.8% |
| Q2 2021 | $666,000 | +2.3% | 675 | -99.9% | 0.83% | +13.2% |
| Q1 2021 | $651,000 | +1.7% | 675,000 | 0.0% | 0.74% | +30.1% |
| Q4 2020 | $640,000 | +29.8% | 675,000 | +25.0% | 0.56% | -18.8% |
| Q3 2020 | $493,000 | – | 540,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 71,162 | $69,799,000 | 4.72% |
| ZAZOVE ASSOCIATES LLC | 27,692,000 | $27,021,000 | 2.38% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 61,727,000 | $60,252,000 | 1.17% |
| SHENKMAN CAPITAL MANAGEMENT INC | 7,637,000 | $7,524,000 | 0.85% |
| NN Investment Partners Holdings N.V. | 38,700,000 | $37,743,000 | 0.30% |
| CAMDEN ASSET MANAGEMENT L P /CA | 5,825,000 | $5,684,000 | 0.18% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 4,479,000 | $4,384,000 | 0.16% |
| Lombard Odier Asset Management (Europe) Ltd | 2,005,000 | $1,905,000 | 0.16% |
| PRUDENTIAL PLC | 41,809,000 | $40,973,000 | 0.12% |
| Calamos Advisors LLC | 22,303,000 | $21,829,000 | 0.12% |